Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Metabotropic Glutamate Receptor 5 Antikörper:
anti-Rat (Rattus) Metabotropic Glutamate Receptor 5 Antikörper:
anti-Mouse (Murine) Metabotropic Glutamate Receptor 5 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Mouse (Murine) Polyclonal Metabotropic Glutamate Receptor 5 Primary Antibody für IHC (fro), IHC - ABIN152473
Spanagel, Pendyala, Abarca, Zghoul, Sanchis-Segura, Magnone, Lascorz, Depner, Holzberg, Soyka, Schreiber, Matsuda, Lathrop, Schumann, Albrecht: The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. in Nature medicine 2005
Show all 2 Pubmed References
This study provides information concerning the changes in the expression of GABAergic and glutamatergic markers in mice lacking the mGlu5.
We report that expr (zeige PAM Antikörper)ession of a key regulator of synaptic protein synthesis, the metabotropic glutamate receptor 5 (mGlu5) protein, is significantly reduced in both the brains of RS model mice and in the motor cortex of human RS autopsy samples.
once at the inner nuclear membrane, mGluR5 is stably retained via interactions with chromatin and is perfectly positioned to regulate nucleoplasmic Ca(2 (zeige CA2 Antikörper)+)in situ
Overall, these data posit mGluR5 in key paralimbic areas as a strong determinant of the temperament trait novelty seeking. These data add to our understanding of how brain neurochemistry accounts for the variation in human behavior and strongly support further research on mGluR5 as a potential therapeutic target in neuropsychiatric disorders associated with abnormal novelty-seeking behaviors.
Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P (zeige TAC1 Antikörper) immunoreactivity in Huntington's disease
The metabotropic glutamate (zeige GRIN1 Antikörper) receptor subtype 5 (mGluR5) has been implicated in the pathophysiology of mood and anxiety disorders.
The interaction between GRM5 and cellular prion protein (zeige PRNP Antikörper) has a central role in transgenic mouse model of Alzheimer's disease pathogenesis.
Data suggest that metabotropic glutamate receptors recycling is completely dependent on the activity of PP2A whereas, PP2B has partial effect on this process.
findings provide evidence for decreased expression of metabotropic glutamate receptor 5 and its signaling components representing a key pathophysiological hallmark in autism spectrum disorder.
Study provided evidence that protein expression of mGluR5 is significantly higher (total: 42%; monomer: 25%; dimer: 52%) in the hippocampal CA1 (zeige CA1 Antikörper) region of schizophrenia subjects relative to healthy controls
Describe a complete knockout mouse model of the autism-associated Shank3 (zeige SHANK3 Antikörper) gene, with a deletion of exons 4-22 (Deltae4-22). Both mGluR5-Homer (zeige HOMER1 Antikörper) scaffolds and mGluR5-mediated signalling are selectively altered in striatal neurons. These changes are associated with perturbed function at striatal synapses, abnormal brain morphology, aberrant structural connectivity and autism spectrum disorder-like behaviour.
Study identified an unexpected age-linked recovery of synaptic gain function in Fragile X (zeige FMR1 Antikörper) syndrome (FXS) model mice medial prefrontal cortex. Stimulus evoked long-term depression mediated by endocannabinoids, absent in early adulthood (2-month-old), is recovered with senescence (at 1-year-old); recovery depends on the engagement of alternative mGlu5 coupled mechanisms.
Study shows that blocking of metabotropic glutamate (zeige GRIN1 Antikörper) type 5 receptor (mGlu5) reduced the dysregulation of glutamate (zeige GRIN1 Antikörper) transmission and improved motor coordination in the Grm1crv4 mouse model of cerebellar ataxia SCAR13 (zeige GRM1 Antikörper).
The authors here demonstrate that metabotropic glutamate (zeige GRIN1 Antikörper) receptors of subtype 5 (mGluR5) contribute to the molecular machinery governing sleep-wake homeostasis.
mGluR5 was significantly more mobile at synapses in hippocampal Fmr1 (zeige FMR1 Antikörper) KO neurons, causing an increased synaptic surface co-clustering of mGluR5 and NMDAR (zeige GRIN1 Antikörper).
Results support positive allosteric modulation of mGlu5, particularly with VU0409551, as a viable mechanism to reverse the deficits in NMDA receptor function, synaptic plasticity, and memory that are known to be impaired in schizophrenia.
Collectively, these results indicate that selective antagonism of glutamate (zeige GRIN1 Antikörper) and mGluR5 has a potentially beneficial effect in both liver cancer and Parkinson's disease, and thus may provide more understanding for the clinical investigation and further an additional therapeutic target for these two diseases.
beta-arrestin2 (zeige ARRB2 Antikörper)-biased negative modulators of mGlu5 offer significant advantages over first-generation inhibitors for the treatment of fragile X (zeige FMR1 Antikörper) and related disorders.
mGluR5 and CB1 (zeige CNR1 Antikörper) act in concert to activate neuroprotective cell signaling pathways and promote neuronal survival.
This study confirmed the presence of mGluR1 (zeige GRM1 Antikörper)/5 complex by (i) reverse immunoprecipitation using an mGluR1 (zeige GRM1 Antikörper) antibody to pulldown mGluR5 from hippocampal tissue.
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene.
metabotropic glutamate receptor 5
, metabotropic glutamate receptor 5 variant F
, metabotropic glutamate receptor 5 variant G
, metabotropic glutamate receptor 5 variant H
, metabotropic glutamate receptor (mGluR5)
, metabotropic glutamate receptor 5b
, G protein coupled receptor, family C, group 1, member E
, G protein-coupled receptor GRM5
, G protein-coupled receptor, family C, group 1, member E
, metabotropic glutamate receptor subtype 5b
, metabotropic glutamate receptor type 5